• Abdullah M Alguwaihes, Amani Alhozali, Moataz M Yahia, Tarek Abdel-Nabi, Mohamed Hassan Hatahet, Nader I Albalkhi, and Saud Al Sifri.
• From the Department of Internal Medicine (Alguwaihes), King Saud University, from the Department of Internal Medicine (Alguwaihes), King Saud University Medical City, from the Department of Medical Affairs (Yahia, Abdel-Nabi), Novo Nordisk, from the Department of Internal Medicine (Albalkhi), Specialized Medical Centre Hospital, Riyadh, from the Department of Internal Medicine (Alhozali), King Abdulaziz University Hospital, Jeddah, from the Department of Internal Medicine (Hatahet), King Abdulaziz Hospital for National Guard, Al Ahsa, and from the Department of Internal Medicine (Al Sifri), Al Hada Military Hospital, Taif, Kingdom of Saudi Arabia.
• Saudi Med J. 2023 Jan 1; 44 (1): 576657-66.

ObjectivesTo investigate cardiovascular disease (CVD) prevalence in adult patients with type 2 diabetes mellitus (T2DM) in Saudi Arabia using data from the CAPTURE cross-sectional study.MethodsCAPTURE was a non-interventional, multinational study carried out between December 2018 and September 2019. In Saudi Arabia, clinical (including medication) and demographic data were collected across 7 sites (Alhada Armed Forces Hospital, Taif; King Saud University Medical City, King Saud University, Riyadh; Specialized Medical Centre Hospital, Riyadh; King Abdulaziz University Hospital, Jeddah; King Abdulaziz Hospital for National Guard, Al Ahsa; Diabetes and Endocrinology Center, Buraidah; and Dallah Hospital, Riyadh, Saudi Arabia) from adults aged ≥18 years. The prevalence of CVD was estimated and weighted according to care setting, with data between groups not statistically compared.ResultsAmong the 883 adults enrolled in this study (566 from primary care, 317 from secondary care), 158 had established CVD, making the weighted prevalence of 18% (95% CI: [15.5-20.5]). The weighted prevalence of atherosclerotic CVD was 15.1% (95% CI: [12.8-17.5]), accounting for 82.4% of the CVD cases. Coronary heart disease was the most common subtype of CVD (13.4%), followed by cerebrovascular disease (1.7%). A total of 23.6% of patients were treated with glucose-lowering agents with proven cardiovascular benefit.ConclusionIn Saudi Arabia, approximately one in 5 adults with T2DM had established CVD, lower than the global prevalence, possibly because of disparities in patient characteristics, potential genetic predispositions, or a lack of accurate documentation due to poor coordination between care settings.Copyright: © Saudi Medical Journal.

18 keywords...

hide…